Extracted from this filing and checked against the source text.
Debt Financings
SEC 8-K Item 2.03/2.04
confidence 0.9
ProSomnus, Inc. incurred convertible notes of $2,000,000 aggregate principal amount with certain existing ProSomnus investors at 9% per annum maturing December 6, 2025.
- Instrument
- convertible notes
- Principal
- $2,000,000 aggregate principal amount
- Counterparty
- certain existing ProSomnus investors
- Rate
- 9% per annum
- Maturity
- December 6, 2025
- Event
- incurrence
Exact text from the filing
On April 17, 2024, ProSomnus, Inc. (the “Company”) issued and sold to certain existing ProSomnus investors $2,000,000 aggregate principal amount of the Company’s Senior Secured Convertible Notes due December 6, 2025
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
ProSomnus, Inc. entered into Additional Notes with certain existing ProSomnus investors valued at $2,000,000 aggregate principal amount (effective 2024-04-17).
- Action
- entry
- Agreement
- notes offering
- Counterparty
- certain existing ProSomnus investors
- Value
- $2,000,000 aggregate principal amount
- Effective
- 2024-04-17
Exact text from the filing
On April 17, 2024, ProSomnus, Inc. (the “Company”) issued and sold to certain existing ProSomnus investors $2,000,000 aggregate principal amount of the Company’s Senior Secured Convertible Notes due December 6, 2025 (the “Additional Notes”) related to that certain Indenture, dated December 6, 2022, as supplemented by the First Supplemental Indenture entered into on June 29, 2023 (the “First Supplemental Indenture”) and the Second Supplemental Indenture entered into on September 20, 2023 (the “Second Supplemental Indenture”), by and among the Company, ProSomnus Holdings, Inc. and ProSomnus Sleep Technologies, Inc., as guarantors (the “Subsidiary Guarantors”), and Wilmington Trust, National Association, as trustee and collateral agent (as so supplemented, the “Indenture”).
View on SEC.gov